Further, breast tumor ER expression may be an important mediator of the transition of TGF-β from tumor suppression to tumor promotion: loss of ER expression (i.e. in ER- tumor cells) and loss of hormonally controlled growth may lead to an increased tumor promoting effect of TGF-β [44]. The gene discussed is ESR1; the disease is breast neoplasm.